Steven A Johnson - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Steven A Johnson

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Movement Disorders : Official Journal of the Movement Disorder Society|March 17, 2025

NLX-112 Randomized Phase 2A Trial: Safety, Tolerability, Anti-Dyskinetic, and Anti-Parkinsonian EfficacyPer Svenningsson, Per Odin, Filip Bergquist, et al.

Environmental Health Perspectives|September 14, 2022

Comparison of State-Level Regulations for Cannabis Contaminants and Implications for Public HealthLaura E Jameson, Kendra D Conrow, Dorina V Pinkhasova, et al.

Journal of Child and Adolescent Psychopharmacology|October 31, 2006

Effect of CX516, an AMPA-modulating compound, on cognition and behavior in fragile X syndrome: a controlled trialElizabeth Berry-Kravis, Sue Ellen Krause, Sandra S Block, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Movement Disorders : Official Journal of the Movement Disorder Society|March 17, 2025

NLX-112 Randomized Phase 2A Trial: Safety, Tolerability, Anti-Dyskinetic, and Anti-Parkinsonian EfficacyPer Svenningsson, Per Odin, Filip Bergquist, et al.

Environmental Health Perspectives|September 14, 2022

Comparison of State-Level Regulations for Cannabis Contaminants and Implications for Public HealthLaura E Jameson, Kendra D Conrow, Dorina V Pinkhasova, et al.

Journal of Child and Adolescent Psychopharmacology|October 31, 2006

Effect of CX516, an AMPA-modulating compound, on cognition and behavior in fragile X syndrome: a controlled trialElizabeth Berry-Kravis, Sue Ellen Krause, Sandra S Block, et al.

Pageof 2